KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) EPS (Weighted Average and Diluted) (2016 - 2026)

Chemed filings provide 18 years of EPS (Weighted Average and Diluted) readings, the most recent being $4.84 for Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) changed 0.41% year-over-year to $4.84, compared with a TTM value of $18.32 through Mar 2026, down 10.72%, and an annual FY2025 reading of $18.34, down 7.79% over the prior year.
  • EPS (Weighted Average and Diluted) hit $4.84 in Q1 2026 for Chemed, down from $5.45 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $6.01 in Q4 2024, with the low at $3.51 in Q2 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $4.46 (2025), compared with a mean of $4.56.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 43.45% in 2023, then dropped 23.23% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $4.12 in 2022, then surged by 43.45% to $5.91 in 2023, then rose by 1.69% to $6.01 in 2024, then decreased by 9.32% to $5.45 in 2025, then decreased by 11.19% to $4.84 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $4.84, $5.45, and $4.46 for Q1 2026, Q4 2025, and Q3 2025 respectively.